Search Ontology:
ChEBI

2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion

Term ID
CHEBI:137581
Synonyms
  • 2-(9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoyl)-sn-glycero-3-phosphoethanolamine zwitterion
  • 2-(prostaglandin E2)-LPE zwitterion
  • 2-(prostaglandin E2)-sn-glycero-3-phosphoethanolamine
  • 2-(prostaglandin E2)-sn-glycero-3-phosphoethanolamine zwitterion
  • 2-azaniumylethyl (2R)-2-{[(5Z,11alpha,13E,15S)-11,15-dihydroxy-1,9-dioxoprosta-5,13-dien-1-yl]oxy}-3-hydroxypropyl phosphate
Definition
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse is_tautomer_of
is_tautomer_of
Phenotype
Phenotype resulting from 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
Phenotype where environments contain 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
Phenotype modified by environments containing 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
Human Disease / Model Data
Citations